Antitumoral activity of Ficus carica L. on colorectal cancer cell lines.


Journal

Cellular and molecular biology (Noisy-le-Grand, France)
ISSN: 1165-158X
Titre abrégé: Cell Mol Biol (Noisy-le-grand)
Pays: France
ID NLM: 9216789

Informations de publication

Date de publication:
31 Jul 2019
Historique:
received: 05 08 2019
accepted: 05 08 2019
entrez: 1 9 2019
pubmed: 1 9 2019
medline: 9 1 2020
Statut: epublish

Résumé

In traditional medicine, Ficus carica (also known as fig) latex is recognized as a remedy with various therapeutic effects. In the present study we investigated the antitumor activity of Ficus carica extracts and latex. We evaluated the effects of increasing concentrations of Ficus carica extracts and latex on HCT-116 and HT-29 human colorectal cell proliferation using MTT assay and apoptosis induction by evaluating PARP cleavage by Western blot analysis. Peel, pulp, leaves, whole fruit and latex extracts of Ficus carica exerted significant antiproliferative effects on HCT-116 (IC50 values 239, 343, 177, 299, 206 µg/ml) and HT-29 cells (IC50 values 207, 249, 230, 261, 182 µg/ml) after 48h of treatment. Furthermore, treatment with different extracts of Ficus carica induced apoptosis in both HT-29 and HCT-116 cancer cells. Leaves and latex extracts of Ficus carica showed the strongest antiproliferative activities. Overall, our results showed that these natural products are strong apoptosis inducers which suggest their use of for therapeutic purposes.

Identifiants

pubmed: 31472041

Substances chimiques

Acetates 0
Antineoplastic Agents 0
Plant Extracts 0
ethyl acetate 76845O8NMZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-11

Auteurs

Hala Soltana (H)

Biochemistry Laboratory, LR12ES05 "Nutrition- Functional Foods and vascular Health", Faculty of Medicine, University of Monastir, Monastir, Tunisia.

Aline Pinon (A)

Laboratory of Chemistry of Natural Substances, Faculty of Pharmacy, University of Limoges, FR 3503 GEIST, EA 1069, Limoges, France.

Youness Limami (Y)

Research Center of Abulcasis University of Health Sciences, Rabat, Morocco.

Younes Zaid (Y)

Research Center of Abulcasis University of Health Sciences, Rabat, Morocco.

Loubna Khalki (L)

Research Center, Mohammed VI University for Health Sciences, Casablanca, Morocco.

Nabil Zaid (N)

Department of biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.

Driss Salah (D)

Department of biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.

Uteuliyev Yerzhan Sabitaliyevich (UY)

Kazakhstan Medical University "KSPH", Kazakhstan.

Alain Simon (A)

Laboratory of Chemistry of Natural Substances, Faculty of Pharmacy, University of Limoges, FR 3503 GEIST, EA 1069, Limoges, France.

Bertrand Liagre (B)

Laboratory of Chemistry of Natural Substances, Faculty of Pharmacy, University of Limoges, FR 3503 GEIST, EA 1069, Limoges, France.

Mohamed Hammami (M)

Biochemistry Laboratory, LR12ES05 "Nutrition- Functional Foods and vascular Health", Faculty of Medicine, University of Monastir, Monastir, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH